Nedotel-M 25 Tablet ER
Marketer
Akned Healthcare Pvt. Ltd.
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Nedotel-M 25 Tablet ER
Hypertension medication, Nedotel-M 25 Extended-Release tablets, effectively manages elevated blood pressure, thus reducing the risk of future cardiovascular events like strokes and heart attacks. Early intervention with this medication significantly enhances survival rates following a heart attack. For consistent blood levels, take Nedotel-M 25 ER daily with food at the same time. Continue treatment as directed by your physician; discontinuing the medication prematurely, even if feeling well, is inadvisable as hypertension often presents without symptoms, potentially worsening your condition. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, further support blood pressure control. Strictly adhere to your doctor's instructions. Potential side effects include headache, weakness, dizziness, hypotension, hyperkalemia, orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, abdominal pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving or stand slowly. Regular monitoring of blood pressure, blood glucose, kidney function, urea, and electrolytes may be required. Inform your doctor of any pre-existing liver or kidney issues, and pregnant or breastfeeding individuals should seek medical counsel before use. Always disclose all other medications, particularly those for hypertension or cardiac conditions.
Uses of Nedotel-M 25 Tablet ER
Treatment of Hypertension (high blood pressure)
Major Benefits of Nedotel-M 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Nedotel-M 25 Tablet ER whole; do not fracture, crush, or chew it. Administer this extended-release tablet with a meal.
Common Side effects of Nedotel-M 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Nedotel-M 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Nedotel-M 25 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Nedotel-M 25 Tablet ER works:
Nedotel-M 25 Tablet ER is a combination of two blood-pressure lowering medicines: Telmisartan and Metoprolol Succinate.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Nedotel-M 25 Tablet ER is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Nedotel-M 25 Tablet ER during pregnancy poses a confirmed risk to the fetus. Prescribing it is exceptionally rare, limited to life-threatening scenarios where potential benefits outweigh known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Nedotel-M 25mg tablets are likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Extended-release Nedotel-M 25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Nedotel-M 25mg tablets are considered safe for individuals with impaired renal function. No modification of the Nedotel-M 25mg ER dosage is necessary.
LiverCAUTION
Patients with hepatic impairment should use Nedotel-M 25 Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Nedotel-M 25 Tablet ER :
Should you forget a dose of Nedotel-M 25 Tablet ER, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nedotel-M 25 Tablet ER
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Heart-related |




